gmp-verlag.de
 

Never ever a 483?

We can not promise that you will never get a 483
but we know that the GMP MANUAL includes all 
procedures and processes you need to be
GMP compliant.
 
Stay informed!

If you’d like to be regularly informed of the latest developments at Good Manufacturing Practices

 

>>> simply register for our free GMP newsletter LOGFILE

 
 

Image

 
 
GMP Subject Downloads

BESTSELLER

1. GDP Audit Checklist
for the Storage and Transport of Pharmaceuticals

 

2. GMP Audit Checklist
for Pharmaceutical and API Manufacturers

 

3. Computer System Validation in the EU
a step-by-step guide to implementing a computer validation program

 

4. Risk Management
established methods of risk analysis
incl. ICH Q9

 

5. Preparing for the EU GMP Inspection
similarities - and subtle differences - between FDA and EU GMP inspections

 

Your benefits:

> no shipping costs
> no waiting period: if you choose payment by credit card you will receive an email with the download information immediately after payment.

 

>>> Click here to see all GMP Subject Downloads!

 

News about GMP/cGMP

EMEA published Annual Report 2008

The European Medicines Agency has published its annual report for 2008, a highly productive year in which the Agency consolidated its work in core activity areas and made good progress with many of the initiatives it is involved in.

 

"The year 2008 was one of consolidation and steady progress for the European Medicines Agency (EMEA), rather than one of major leaps and bounds.

However, set against a background of continuing globalisation of the pharmaceutical sector, further
rapid advances in medical science and the unrelenting pace of regulatory activity in the medicines
network of the European Union (EU), it was by no means a ‘dull’ year for the Agency.
As pharmaceutical development and clinical trials of medicines move increasingly beyond the
traditional spheres of Europe and North America, regulators are becoming more keenly aware of the
need for international cooperation on ensuring that safe and ethical practices are being used for the
development and testing of medicinal products in all parts of the world. In 2008, the Agency intensified
its cooperation with international partners to ensure its contribution to global efforts for safer and better
medicines around the world.

However, set against a background of continuing globalisation of the pharmaceutical sector, further rapid advances in medical science and the unrelenting pace of regulatory activity in the medicines network of the European Union (EU), it was by no means a ‘dull’ year for the Agency.

As pharmaceutical development and clinical trials of medicines move increasingly beyond the traditional spheres of Europe and North America, regulators are becoming more keenly aware of the need for international cooperation on ensuring that safe and ethical practices are being used for the development and testing of medicinal products in all parts of the world. In 2008, the Agency intensified its cooperation with international partners to ensure its contribution to global efforts for safer and better medicines around the world. [...]"

Source: Summary of the European Medicines Agency’s annual report for 2008, EMEA, 2009, EMEA/362115/2009

Annual report Summary (17 pages)

Annual report ful (158 pages)

 

Comments
No comment have jet been written about this news